Chronic obstructive pulmonary disease, neutrophils and bacteria: from science to integrated care pathways

ISSN： 1470-2118

Source： Clinical Medicine, Vol.4, Iss.6, 2004-11, pp. : 567-572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite

Roflumilast: In Chronic Obstructive Pulmonary Disease

By Sanford Mark

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1615-1627

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of chronic obstructive pulmonary disease

By Hizawa Nobuyuki

Pharmacogenomics, Vol. 14, Iss. 10, 2013-07 ,pp. : 1215-1225

Future Medicine

Access to resources Recommend Favorite

Aclidinium: In Chronic Obstructive Pulmonary Disease

By Frampton James E.

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 1999-2011

Adis International

Access to resources Recommend Favorite

Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient

By Parameswaran G. Iyer Murphy Timothy F.

Drugs & Aging, Vol. 26, Iss. 12, 2009-12 ,pp. : 985-995

Adis International

Access to resources Recommend Favorite